CompariSon of Manual Aspiration With Rheolytic Thrombectomy in Patients Undergoing Primary PCI. The SMART-PCI Trial
SMART
1 other identifier
interventional
80
1 country
1
Brief Summary
To compare rheolytic thrombectomy (RT) with manual thrombus aspiration (MTA) in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI. Occlusive thrombosis triggered by a disrupted or eroded atherosclerotic plaque is the anatomic substrate of ST-segment elevation myocardial infarction (STEMI). Due to this substrate, macro- and microembolization during percutaneous coronary intervention (PCI) in AMI is frequent and may result in obstruction of the microvessel network, and decreased efficacy of reperfusion and myocardial salvage. Direct stenting without predilation or postdilation is the most simplistic approach to the problem of embolization, and may decrease embolization and the incidence of the no-reflow phenomenon. Other approaches to the problem of microvessel embolization include thrombectomy before stent implantation, and the use of antiembolic devices (filters and occlusive devices with retrieval of thromboembolic material after stent implantation). Most concluded studies on removing of thrombus before stenting used manual aspiration catheters and meta-analyses derived from these studies support the use of manual thrombus aspiration (MTA) catheters in the setting of primary PCI. MTA is currently recommended in the setting of primary PCI as a Class II b recommendation; level of evidence B. Rheolytic thrombectomy (RT) using multiple jets of saline solution and aspiration based on the Bernoulli effect has been proven to be effective in decreasing major adverse events during PCI in saphenous vein grafts or native coronary arteries with angiographic evidence of thrombus, and 2 out of 3 concluded studies have shown a better reperfusion and clinical outcome in patients randomized to RT as compared to control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Dec 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 18, 2011
CompletedFirst Posted
Study publicly available on registry
January 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedAugust 1, 2013
July 1, 2013
11 months
January 18, 2011
July 31, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-thrombectomy thrombus burden as assessed by coronary OCT
OCT images analysis. The primary end-point of the study will be the number of thrombus containing vascular quadrants considering vascular slices.
baseline
Secondary Outcomes (10)
Angiographic thrombus grade after thrombectomy
baseline
ST-segment resolution at 30 minutes post-PCI, assessed by 12-lead ECG
30 minutes
Angiographic markers of reperfusion:TIMI flow grade, TIMI myocardial blush.
baseline
Procedural angiographic complications : distal embolization, no-reflow, perforation, dissection.
baseline
Infarct size and microvascular obstruction measured by MRI at 3-7 days
3-7 days
- +5 more secondary outcomes
Study Arms (2)
thrombus-aspiration group
ACTIVE COMPARATORIn patients in the thrombus-aspiration group, the thrombus-aspiration is manually performed.
AngioJet Rheolytic Thrombectomy
EXPERIMENTALAngioJet Rheolytic Thrombectomy (RT) System consists of a drive unit console, disposable pump set, and disposable catheter.
Interventions
In patients in the thrombus-aspiration group, this step is followed by the advancing of the 6-French Export Aspiration Catheter (Medtronic; crossing profile, 0.068 in.) into the target coronary segment during continuous aspiration.
The AngioJet Rheolytic Thrombectomy (RT) System consists of a drive unit console, disposable pump set, and disposable catheter. Thrombectomy is accomplished by the introduction of a pressurized high velocity saline stream through directed orifices in the catheter distal tip so that thrombus is entrained (Bernoulli effect), dissociated into small particles, and evacuated from the body through the catheter and associated tubing. The pump set consists of a high pressure pulsatile pump which is used to generate the flow necessary for the dissociation and evacuation of thrombus, an effluent bag for the collection and storage of thrombus debris, and associated tubing.
Eligibility Criteria
You may qualify if:
- Patient is \> 18 years of age.
- Patient has ST-segment elevation of at least 0.1 mV in 2 or more contiguous leads or presumably new LBBB for all types of infarcts.
- Patient's AMI presentation is greater than 30 minutes but less than 6 hours after symptom onset.
- Patient provides written informed consent. Patient has no childbearing potential or is not pregnant
- All patients with or without evidence of thrombus are eligible.
- Target artery has a reference vessel diameter 2.5 mm on visual assessment at baseline angiography.
You may not qualify if:
- Known prior history of renal insufficiency (serum creatinine 2.0 mg/dL).
- Cardiogenic shock.
- Prior administration of thrombolysis for the current infarction.
- Participation in another study.
- Major surgery within past 6 weeks.
- History of stroke within 30 days, or any history of hemorrhagic stroke.
- Severe hypertension (systolic BP \> 200 mm Hg or diastolic BP \> 110 mm Hg) not controlled on antihypertensive therapy.
- Known neutropenia ( \<1000 neutrophils per mm3) or known severe thrombocytopenia (\< 50,000 platelets per mm3).
- Patient unwilling to receive blood products
- Previously stented IRA (stent thrombosis).
- Inability to identify the IRA.
- Severe vessel tortuosity that enables OCT assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Careggi Hospitallead
- Cardiovascular Research Foundation, New Yorkcollaborator
Study Sites (1)
Careggi Hospital
Florence, 50134, Italy
Related Publications (1)
Parodi G, Valenti R, Migliorini A, Maehara A, Vergara R, Carrabba N, Mintz GS, Antoniucci D. Comparison of manual thrombus aspiration with rheolytic thrombectomy in acute myocardial infarction. Circ Cardiovasc Interv. 2013 Jun;6(3):224-30. doi: 10.1161/CIRCINTERVENTIONS.112.000172. Epub 2013 Jun 4.
PMID: 23735474DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Antoniucci, MD
Careggi Hospital, Division of Invasive Cardiology
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 18, 2011
First Posted
January 21, 2011
Study Start
December 1, 2010
Primary Completion
November 1, 2011
Study Completion
March 1, 2012
Last Updated
August 1, 2013
Record last verified: 2013-07